KVV21401
HSV-1/HHV-1 gD
Colorimetric
Plasma, Serum
Quantitative
1.56 - 100 ng/mL
0.65 ng/mL
CV<15%
80-120%
2-8 ℃
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Anti-herpes simplex virus type 1 activity of the Rohdea chinensis (Baker) N. Tanaka aqueous extracts., PMID:40412773
Design, synthesis, and in-vitro/in-vivo pharmacodynamic studies of novel aza-fused heterocyclic compounds against herpes simplex virus type 1., PMID:40403497
Herpes simplex virus 1 fusion glycoprotein B H516P prefusion mutation had no effect on vaccine immunogenicity., PMID:40354699
A potent protective bispecific nanobody targeting Herpes simplex virus gD reveals vulnerable epitope for neutralizing., PMID:40328740
Herpes simplex virus 1 glycoprotein C promotes virus penetration from endosomes during entry, independent of interaction with heparan sulfate., PMID:40270821
A tissue-targeted prime/pull/keep therapeutic herpes simplex virus vaccine protects against recurrent ocular herpes infection and disease in HLA-A*0201 transgenic rabbits., PMID:40207928
Neuron-restricted cytomegalovirus latency in the central nervous system regulated by CD4+ T-cells and IFN-γ., PMID:40158177
Analysis of the Interaction Between the Attenuated HSV-1 Strain M6 and Macrophages Indicates Its Potential as an Effective Vaccine Immunogen., PMID:40143320
Herpes simplex virus 1 envelope glycoprotein C shields glycoprotein D to protect virions from entry-blocking antibodies., PMID:40135897
Recent developments in gene therapy for Parkinson's disease., PMID:40121531
The combined effects of HSV-1 glycoprotein D and aluminum hydroxide on human neuroblastoma cells: Insights into oxidative DNA damage, apoptosis, and epigenetic modifications., PMID:40112954
Quantum Chemical and Metabolomic Characterization of Inhibitory Activity of Procyanidins and Flavonol Glucosides From Graptopetalum paraguayense E. Walther Against Nonstructural Proteins of SARS-CoV-2., PMID:40067310
Targeting Herpes Simplex Virus Glycoprotein D with Bispecific Antibodies: Expanding Therapeutic Horizons by Searching for Synergy., PMID:40007004
CRISPR/Cas9 Eye Drop HSV-1 Treatment Reduces Brain Viral Load: A Novel Application to Prevent Neuronal Damage., PMID:39770347
Standardized Eucalyptus maculata (Corymbia maculata) Resin Extract: Metabolomic Profiling, In Vitro and In Silico Study of Anti-HSV Activity., PMID:39638765
Improving antibody-mediated protection against HSV infection by eliminating interactions with the viral Fc receptor gE/gI., PMID:39605495
Aescin Inhibits Herpes simplex Virus Type 1 Induced Membrane Fusion., PMID:39442532
Efficient Strategy for Synthesizing Vector-Free and Oncolytic Herpes Simplex Type 1 Viruses., PMID:39358309
Immunogenicity and protective efficacy of a recombinant lactococcus lactis vaccine against HSV-1 infection., PMID:39252072
A novel GFP-based strategy to quantitate cellular spatial associations in HSV-1 viral pathogenesis., PMID:39248563
Herpes Simplex Virus 1 Envelope Glycoprotein C Shields Glycoprotein D to Protect Virions from Entry-Blocking Antibodies., PMID:39229192
TMEFF1 is a neuron-specific restriction factor for herpes simplex virus., PMID:39048823
Alphaherpesvirus manipulates retinoic acid metabolism for optimal replication., PMID:38989466
Preclinical Immunogenicity and Efficacy Studies for Therapeutic Vaccines for Human Papillomavirus-Type-16-Associated Cancer., PMID:38932345
Development of an HSV-1 production process involving serum-reduced culturing and bead-to-bead transfer., PMID:38896301
Human Antibodies against Herpes Simplex Virus 2 Glycoprotein G Do Not Neutralize but Mediate Antibody-Dependent Cellular Cytotoxicity., PMID:38804308
Anti-HSV activity of nectin-1-derived peptides targeting HSV gD: an in-silico and in-vitro approach., PMID:38720617
A programmable targeted protein-degradation platform for versatile applications in mammalian cells and mice., PMID:38479385
Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models., PMID:38473739
Downregulation of endogenous nectin1 in human keratinocytes by herpes simplex virus 1 glycoprotein D excludes superinfection but does not affect NK cell function., PMID:38471041
Histone H2A variant H2A.B is enriched in transcriptionally active and replicating HSV-1 lytic chromatin., PMID:38451083
Herpes Simplex Virus 1 Glycoprotein B from a Hyperfusogenic Virus Mediates Enhanced Cell-Cell Fusion., PMID:38400027
The transmembrane and cytosolic domains of equine herpesvirus type 1 glycoprotein D determine Golgi retention by regulating vesicle formation., PMID:38340657
Herpes simplex virus infection induces necroptosis of neurons and astrocytes in human fetal organotypic brain slice cultures., PMID:38302975
Prunella vulgaris polysaccharide inhibits herpes simplex virus infection by blocking TLR-mediated NF-κB activation., PMID:38185640
Chemical Synthesis Creates Single Glycoforms of the Ectodomain of Herpes Simplex Virus-1 Glycoprotein D., PMID:38117537
Membrane fusion activity of herpes simplex virus 1 glycoproteins from a hyperfusogenic virus., PMID:38106075
Citrullination profile analysis reveals peptidylarginine deaminase 3 as an HSV-1 target to dampen the activity of candidate antiviral restriction factors., PMID:38055760
Anti-Herpes Simplex Virus Type 1 Activity Evaluation of Natural Derived Phloroglucinol Derivatives and Their Molecular Mechanisms Study., PMID:38009609
Shared sequence characteristics identified in non-canonical rearrangements of HSV-1 genomes., PMID:37991369
Targeted delivery of herpes simplex virus glycoprotein D to CD169+ macrophages using ganglioside liposomes alleviates herpes simplex keratitis in mice., PMID:37981051
Selection, activity, and nuclease stabilization of cross-neutralizing DNA aptamers targeting HSV-1 and HSV-2., PMID:37925791
Binding of herpesvirus entry mediator (HVEM) and HSV-1 gD affect reactivation but not latency levels., PMID:37738264
Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer., PMID:37701851
Herpes Simplex Virus Type 1 Infection Induces the Formation of Tunneling Nanotubes., PMID:37630476
The Cooperation of IL-29 and PLGA Nanoparticles Improves the Protective Immunity of the gD-1 DNA Vaccine Against Herpes Simplex Virus Type 1 in Mice., PMID:37610337
OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment., PMID:37554264
CLEAR Strategy Inhibited HSV Proliferation Using Viral Vectors Delivered CRISPR-Cas9., PMID:37375504
METTL3-mediated m6A RNA modification promotes corneal neovascularization by upregulating the canonical Wnt pathway during HSV-1 infection., PMID:37356601
Varicella-zoster virus proteome-wide T-cell screening demonstrates low prevalence of virus-specific CD8 T-cells in latently infected human trigeminal ganglia., PMID:37308917
Order: order@antibodysystem.com
Mail: support@antibodysystem.com
For research use only. Not for human or drug use.
Find out more about placing an order here
